Combination chemoimmunotherapy using alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (campath-FCD) is an effective first-line regimen in peripheral T-celll lymphomas

Weidmann, Eckhart and Hess, Georg and Krause, Stefan W. and Hebart, Holger and Dreyling, Martin and Subklewe, Marion and Falge, Christine and Chow, Kai U. and Jaeger, Elke and Mitrou, Parisis S. (2004) Combination chemoimmunotherapy using alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (campath-FCD) is an effective first-line regimen in peripheral T-celll lymphomas. In: 46th Annual Meeting of the American Society of Hematology, December 04-07, 2004, San Diego, CA.

Full text not available from this repository.
Item Type: Conference or Workshop Item (Poster)
Additional Information: Band lag vor /gup
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 27 Oct 2021 06:19
Last Modified: 27 Oct 2021 06:19
URI: https://pred.uni-regensburg.de/id/eprint/36958

Actions (login required)

View Item View Item